CDKN2A and astrocytoma (excluding glioblastoma): Despite this, 4 astrocytomas exhibited codeletion of CDKN2A/B on CNV profiling, thus carrying a far worse prognosis (CNS WHO Grade 4) than the methylation class alone would indicate (likely CNS WHO Grade 2).